SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc., a biopharmaceutical company discovering and developing novel therapeutics for the treatment of Parkinson’s disease, Alzheimer’s disease and other ...
SAN DIEGO & BRUSSELS--Neuropore Therapies Inc. and UCB announced today that they have entered into a world-wide collaboration and agreement to develop and commercialize therapeutic products aiming at ...
SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc. announced today that it has commenced Phase 1 clinical trials with NPT200-11, a novel potential treatment for Parkinson’s Disease. “We are pleased ...
In this report we describe the developmental expression and function of Sp8, a member of the Sp family of zinc finger transcription factors, and provide evidence that the legless transgene insertional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback